Xiao Y - Search Results

1

A novel NIR-II probe for improved tumor-targeting NIR-II imaging.

Hu C, Guo T, Li H, Xu P, Xiao Y. Hu C, et al. Among authors: xiao y. RSC Adv. 2021 Dec 9;11(62):39287-39290. doi: 10.1039/d1ra07135a. eCollection 2021 Dec 6. RSC Adv. 2021. PMID: 35492481 Free PMC article.

2

Conventional versus drug-eluting beads chemoembolization for infiltrative hepatocellular carcinoma: a comparison of efficacy and safety.

Zhang ZS, Li HZ, Ma C, Xiao YD. Zhang ZS, et al. BMC Cancer. 2019 Nov 29;19(1):1162. doi: 10.1186/s12885-019-6386-6. BMC Cancer. 2019. PMID: 31783814 Free PMC article.

3

Chemoembolization Plus Microwave Ablation vs Chemoembolization Alone in Unresectable Hepatocellular Carcinoma Beyond the Milan Criteria: A Propensity Scoring Matching Study.

Li HZ, Tan J, Tang T, An TZ, Li JX, Xiao YD. Li HZ, et al. J Hepatocell Carcinoma. 2021 Nov 1;8:1311-1322. doi: 10.2147/JHC.S338456. eCollection 2021. J Hepatocell Carcinoma. 2021. PMID: 34754838 Free PMC article.

4

Identification of NOX4 as a New Biomarker in Hepatocellular Carcinoma and Its Effect on Sorafenib Therapy.

Li HZ, Liu QQ, Chang DH, Li SX, Yang LT, Zhou P, Deng JB, Huang CH, Xiao YD. Li HZ, et al. Biomedicines. 2023 Aug 4;11(8):2196. doi: 10.3390/biomedicines11082196. Biomedicines. 2023. PMID: 37626693 Free PMC article.

5

Prognostic Factors for Patients with Proliferative Hepatocellular Carcinoma After Liver Resection.

Li HM, Huang W, Hu C, Zhang ZS, Xiao YD, Wang TC. Li HM, et al. J Hepatocell Carcinoma. 2023 Nov 20;10:2059-2071. doi: 10.2147/JHC.S440636. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 38022727 Free PMC article.

6

CD36-mediated accumulation of MDSCs exerts abscopal immunosuppressive responses in hepatocellular carcinoma after insufficient microwave ablation.

Liu QQ, Li HZ, Li SX, Bao Y, Wang TC, Hu C, Xiao YD. Liu QQ, et al. Among authors: xiao yd. Biochim Biophys Acta Mol Basis Dis. 2024 Dec;1870(8):167493. doi: 10.1016/j.bbadis.2024.167493. Epub 2024 Sep 2. Biochim Biophys Acta Mol Basis Dis. 2024. PMID: 39233261

7

A predictive model of incomplete response after transarterial chemoembolization for early or intermediate stage of hepatocellular carcinoma: consideration of hepatic angiographic and cross-sectional imaging.

Tao PY, Zhang ZS, Wang TC, Yu MQ, Xiao YD. Tao PY, et al. Abdom Radiol (NY). 2021 Feb;46(2):581-589. doi: 10.1007/s00261-020-02701-5. Epub 2020 Aug 6. Abdom Radiol (NY). 2021. PMID: 32761406

8

MRI contrast agents: Classification and application (Review).

Xiao YD, Paudel R, Liu J, Ma C, Zhang ZS, Zhou SK. Xiao YD, et al. Int J Mol Med. 2016 Nov;38(5):1319-1326. doi: 10.3892/ijmm.2016.2744. Epub 2016 Sep 21. Int J Mol Med. 2016. PMID: 27666161 Review.

9

Magnetic resonance imaging of intracranial hemangiopericytoma and correlation with pathological findings.

Ma C, Xu F, Xiao YD, Paudel R, Sun Y, Xiao EH. Ma C, et al. Among authors: xiao eh, xiao yd. Oncol Lett. 2014 Nov;8(5):2140-2144. doi: 10.3892/ol.2014.2503. Epub 2014 Sep 4. Oncol Lett. 2014. PMID: 25289095 Free PMC article.

10

Pituitary metastasis of choriocarcinoma: A case report.

Liu H, Xiao YD, Peng SP, Zhou SK, Liu J. Liu H, et al. Oncol Lett. 2016 Feb;11(2):1517-1520. doi: 10.3892/ol.2016.4088. Epub 2016 Jan 8. Oncol Lett. 2016. PMID: 26893772 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,926 results

Search Page

Filters